MEwens
Very early results from research into embryonic stem cell treatments suggest that the therapy was safe in use against macular degeneration, a major cause of blindness. The findings, though preliminary, are the first published results involving embryonic stem cells in human patients.
In the report, which covered two patients followed over four months, the […]
Continued Read ...
MEwens
Moving Forward: Pfizer and a group of researchers are waiting for permission to initiate a human study in the U.K. of a possible treatment for age-related macular degeneration that is derived from human embryonic stem cells, the WSJ reports. It’s a sign that research on the controversial cells is moving forward into actual […]
Continued Read ...
MEwens
XMRV Theory Dealt a Blow: Scientists are backing off a controversial paper that linked a retrovirus called XMRV to chronic fatigue syndrome, and a working group looking at the issue says there’s now no reason to screen the blood supply for the virus, the WSJ reports. Two authors of the original 2009 study, […]
Continued Read ...
MEwens
Choosing a Spinoff: Pfizer is more likely to spin off its animal health division than to sell it, the WSJ reports, citing people familiar with the matter. The pharma company is still likely to entertain offers for the business, which could be worth as much as $15 billion, but tax and antitrust considerations […]
Continued Read ...
Laura Landro
Also: aspirin and cancer; embryonic stem-cell arguments; back to McAllen, Texas, this time to look at private insurance.
Read more this great post here
Continued Read ...
Katherine Hobson
Also: most Americans now probably immune to 2009 H1N1 strain; federally funded embryonic stem cell research can continue — for now.
Read more this great post here
Continued Read ...
Laura Landro
Also: advocates press for coverage of custom-made breast prostheses; Seattle Genetics reports positive drug results; obese women pay more than men.
Read more this great post here
Continued Read ...
MEwens
The appeals court could make a decision later the month on whether funding should be allowed to continue as the case proceeds.
Read more this great post here
Continued Read ...
Amy Dockser Marcus
Also: Consumer Reports publishes surgery group ratings; judge won’t stay stem cell ruling; gender differences in mild cognitive impairment.
Read more this great post here
Continued Read ...
MEwens
Also: Stem cell legislation in the House; Abbott ends an auction; NYC public hospitals prepare for some changes.
Read more this great post here
Continued Read ...
